AAAAAA

   
Results: 1-14 |
Results: 14
L-743,726 (DMP-266) - A NOVEL, HIGHLY POTENT NONNUCLEOSIDE INHIBITOR OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE
Authors: YOUNG SD BRITCHER SF TRAN LO PAYNE LS LUMMA WC LYLE TA HUFF JR ANDERSON PS OLSEN DB CARROLL SS PETTIBONE DJ OBRIEN JA BALL RG BALANI SK LIN JH CHEN IW SCHLEIF WA SARDANA VV LONG WJ BYRNES VW EMINI EA
Citation: Sd. Young et al., L-743,726 (DMP-266) - A NOVEL, HIGHLY POTENT NONNUCLEOSIDE INHIBITOR OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE, Antimicrobial agents and chemotherapy, 39(12), 1995, pp. 2602-2605
ATTEMPTED PROPHYLAXIS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION IN CHIMPANZEES WITH A NONNUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITOR
Authors: SCHLEIF WA MURTHY KK SARDANA VV SCHNEIDER CL BYRNES VW COBB KE ROTH E WOLFGANG JA HOFFMAN JM SMITH AM GELOTTE KM EMINI EA
Citation: Wa. Schleif et al., ATTEMPTED PROPHYLAXIS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION IN CHIMPANZEES WITH A NONNUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITOR, AIDS research and human retroviruses, 10(1), 1994, pp. 107-110
MUTATIONS IN HIV-1 PROTEASE RESIDUES AFFECTING SUSCEPTIBILITY TO L-735,524
Authors: CONDRA JH BLAHY OM BUSH BL CULBERSON C GOTLIB L GRAHAM DJ GRAHAM PL HOLLOWAY MK LAFEMINA RL QUINTERO JC RHODES A ROTH E SARDANA VV SCHNEIDER CL SCHLABACH AJ SCHLEIF WA TITUS DL WOLANSKI BS WOLFGANG JA EMINI EA
Citation: Jh. Condra et al., MUTATIONS IN HIV-1 PROTEASE RESIDUES AFFECTING SUSCEPTIBILITY TO L-735,524, Journal of cellular biochemistry, 1994, pp. 166-166
THE GENETIC AND FUNCTIONAL BASIS OF HIV-1 RESISTANCE TO NONNUCLEOSIDEREVERSE-TRANSCRIPTASE INHIBITORS
Authors: EMINI EA BYRNES VW CONDRA JH SCHLEIF WA SARDANA VV
Citation: Ea. Emini et al., THE GENETIC AND FUNCTIONAL BASIS OF HIV-1 RESISTANCE TO NONNUCLEOSIDEREVERSE-TRANSCRIPTASE INHIBITORS, Archives of virology, 1994, pp. 11-17
SUSCEPTIBILITIES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENZYME AND VIRAL VARIANTS EXPRESSING MULTIPLE RESISTANCE-ENGENDERING AMINO-ACID SUBSTITUTIONS TO REVERSE-TRANSCRIPTASE INHIBITORS
Authors: BYRNES VW EMINI EA SCHLEIF WA CONDRA JH SCHNEIDER CL LONG WJ WOLFGANG JA GRAHAM DJ GOTLIB L SCHLABACH AJ WOLANSKI BS BLAHY OM QUINTERO JC RHODES A ROTH E TITUS DL SARDANA VV
Citation: Vw. Byrnes et al., SUSCEPTIBILITIES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENZYME AND VIRAL VARIANTS EXPRESSING MULTIPLE RESISTANCE-ENGENDERING AMINO-ACID SUBSTITUTIONS TO REVERSE-TRANSCRIPTASE INHIBITORS, Antimicrobial agents and chemotherapy, 38(6), 1994, pp. 1404-1407
L-735,524 - AN ORALLY BIOAVAILABLE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROTEASE INHIBITOR
Authors: VACCA JP DORSEY BD SCHLEIF WA LEVIN RB MCDANIEL SL DARKE PL ZUGAY J QUINTERO JC BLAHY OM ROTH E SARDANA VV SCHLABACH AJ GRAHAM PI CONDRA JH GOTLIB L HOLLOWAY MK LIN J CHEN IW VASTAG K OSTOVIC D ANDERSON PS EMINI EA HUFF JR
Citation: Jp. Vacca et al., L-735,524 - AN ORALLY BIOAVAILABLE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROTEASE INHIBITOR, Proceedings of the National Academy of Sciences of the United Statesof America, 91(9), 1994, pp. 4096-4100
HUMAN-IMMUNODEFICIENCY-VIRUS-1 (HIV-1)-SPECIFIC REVERSE-TRANSCRIPTASE(RT) INHIBITORS MAY SUPPRESS THE REPLICATION OF SPECIFIC DRUG-RESISTANT (E138K)RT HIV-1 MUTANTS OR SELECT FOR HIGHLY RESISTANT (Y181C-]C181I)RT HIV-1 MUTANTS
Authors: BALZARINI J KARLSSON A SARDANA VV EMINI EA CAMARASA MJ DECLERCQ E
Citation: J. Balzarini et al., HUMAN-IMMUNODEFICIENCY-VIRUS-1 (HIV-1)-SPECIFIC REVERSE-TRANSCRIPTASE(RT) INHIBITORS MAY SUPPRESS THE REPLICATION OF SPECIFIC DRUG-RESISTANT (E138K)RT HIV-1 MUTANTS OR SELECT FOR HIGHLY RESISTANT (Y181C-]C181I)RT HIV-1 MUTANTS, Proceedings of the National Academy of Sciences of the United Statesof America, 91(14), 1994, pp. 6599-6603
PEPTIDE SUBSTRATE CLEAVAGE SPECIFICITY OF THE HUMAN CYTOMEGALOVIRUS PROTEASE
Authors: SARDANA VV WOLFGANG JA VELOSKI CA LONG WJ LEGROW K WOLANSKI B EMINI EA LAFEMINA RL
Citation: Vv. Sardana et al., PEPTIDE SUBSTRATE CLEAVAGE SPECIFICITY OF THE HUMAN CYTOMEGALOVIRUS PROTEASE, The Journal of biological chemistry, 269(20), 1994, pp. 14337-14340
HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROTEASE INHIBITORS - EVALUATION OF RESISTANCE ENGENDERED BY AMINO-ACID SUBSTITUTIONS IN THE ENZYMES SUBSTRATE-BINDING SITE
Authors: SARDANA VV SCHLABACH AJ GRAHAM P BUSH BL CONDRA JH CULBERSON JC GOTLIB L GRAHAM DJ KOHL NE LAFEMINA RL SCHNEIDER CL WOLANSKI BS WOLFGANG JA EMINI EA
Citation: Vv. Sardana et al., HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROTEASE INHIBITORS - EVALUATION OF RESISTANCE ENGENDERED BY AMINO-ACID SUBSTITUTIONS IN THE ENZYMES SUBSTRATE-BINDING SITE, Biochemistry, 33(8), 1994, pp. 2004-2010
PREVENTION OF HIV-1 INFECTION IN CHIMPANZEES BY A NONNUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITOR
Authors: SCHLEIF WA SARDANA VV BYRNES VW MURTHY KK EMINI EA
Citation: Wa. Schleif et al., PREVENTION OF HIV-1 INFECTION IN CHIMPANZEES BY A NONNUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITOR, Journal of cellular biochemistry, 1993, pp. 23-23
HIV-1 REVERSE-TRANSCRIPTASE RESIDUES THAT INFLUENCE SENSITIVITY TO NONNUCLEOSIDE INHIBITORS
Authors: BYRNES VW SARDANA VV CONDRA JH SCHLEIF WA SCHNEIDER CL WATERBURY JA WOLFGANG JA GRAHAM DJ GOTLIB L SCHLABACH AJ WOLANSKI BS LONG WJ RHODES A TITUS DL ROTH E BLAHY OM EMINI EA
Citation: Vw. Byrnes et al., HIV-1 REVERSE-TRANSCRIPTASE RESIDUES THAT INFLUENCE SENSITIVITY TO NONNUCLEOSIDE INHIBITORS, Journal of cellular biochemistry, 1993, pp. 75-75
COMPREHENSIVE MUTANT ENZYME AND VIRAL VARIANT ASSESSMENT OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE RESISTANCE TO NONNUCLEOSIDE INHIBITORS
Authors: BYRNES VW SARDANA VV SCHLEIF WA CONDRA JH WATERBURY JA WOLFGANG JA LONG WJ SCHNEIDER CL SCHLABACH AJ WOLANSKI BS GRAHAM DJ GOTLIB L RHODES A TITUS DL ROTH E BLAHY OM QUINTERO JC STASZEWSKI S EMINI EA
Citation: Vw. Byrnes et al., COMPREHENSIVE MUTANT ENZYME AND VIRAL VARIANT ASSESSMENT OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE RESISTANCE TO NONNUCLEOSIDE INHIBITORS, Antimicrobial agents and chemotherapy, 37(8), 1993, pp. 1576-1579
A NONNUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITOR ACTIVE ON HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ISOLATES RESISTANT TO RELATED INHIBITORS
Authors: GOLDMAN ME OBRIEN JA RUFFING TL SCHLEIF WA SARDANA VV BYRNES VW CONDRA JH HOFFMAN JM EMINI EA
Citation: Me. Goldman et al., A NONNUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITOR ACTIVE ON HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ISOLATES RESISTANT TO RELATED INHIBITORS, Antimicrobial agents and chemotherapy, 37(5), 1993, pp. 947-949
5-CHLORO-3-(PHENYLSULFONYL)INDOLE-2-CARBOXAMIDE - A NOVEL, NONNUCLEOSIDE INHIBITOR OF HIV-1 REVERSE-TRANSCRIPTASE
Authors: WILLIAMS TM CICCARONE TM MACTOUGH SC ROONEY CS BALANI SK CONDRA JH EMINI EA GOLDMAN ME GREENLEE WJ KAUFFMAN LR OBRIEN JA SARDANA VV SCHLEIF WA THEOHARIDES AD ANDERSON PS
Citation: Tm. Williams et al., 5-CHLORO-3-(PHENYLSULFONYL)INDOLE-2-CARBOXAMIDE - A NOVEL, NONNUCLEOSIDE INHIBITOR OF HIV-1 REVERSE-TRANSCRIPTASE, Journal of medicinal chemistry, 36(9), 1993, pp. 1291-1294
Risultati: 1-14 |